Literature DB >> 12559675

A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment.

Rachida Essalihi1, Huy Hao Dao, Nobuharu Yamaguchi, Pierre Moreau.   

Abstract

BACKGROUND: Isolated systolic hypertension is the predominant form of hypertension in the elderly population. Reduction of arterial compliance appears to contribute to the elevation of pulse pressure (PP) and among potential mechanisms, gradual vascular calcification, fragmentation of elastic lamellae, and augmentation of rigid component like collagen could contribute to increase aortic stiffening. Few experimental models of the disease are currently available.
METHODS: To induce large artery calcification, rats were treated with warfarin and vitamin K(1) (WK) for 4 and 8 weeks, to inhibit the maturation of matrix Gla protein. The impact of chronic PP elevation was determined on large artery and cardiac remodeling and on aortic endothelial function.
RESULTS: The WK treatment led to aortic medial calcification and a proportional elevation of PP, attributable mainly to a selective elevation of systolic blood pressure. The chronic treatment also increased collagen, whereas elastin decreased in the aorta. Pulse wave velocity, an index of aortic stiffening, increased in rats treated with WK. However, indices of left ventricular and aortic hypertrophy and remodeling remained normal. In addition, the WK treatment did not modify the vasoconstriction to norepinephrine and endothelin-1, and the vasodilatory response to acetylcholine and sodium nitroprusside.
CONCLUSIONS: Chronic treatment with WK represents a new model of isolated systolic hypertension with several characteristics of the human disease. The relative ease to induce calcification in this model may help to foster more fundamental research, which is lacking in this type of hypertension. Copyright 2003 American Journal of Hypertension, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559675     DOI: 10.1016/s0895-7061(02)03204-1

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  21 in total

1.  Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification.

Authors:  Kelly E Beazley; Stephanie Deasey; Florence Lima; Maria V Nurminskaya
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

Review 2.  Arterial stiffness and hypertension: chicken or egg?

Authors:  Gary F Mitchell
Journal:  Hypertension       Date:  2014-08       Impact factor: 10.190

Review 3.  Killing Me Unsoftly: Causes and Mechanisms of Arterial Stiffness.

Authors:  Alicia N Lyle; Uwe Raaz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02       Impact factor: 8.311

4.  Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Authors:  Kelly E Beazley; Saman Eghtesad; Maria V Nurminskaya
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

5.  Association of linear ¹⁸F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors: a PET/CT study.

Authors:  Tido Janssen; Peter Bannas; Jochen Herrmann; Simon Veldhoen; Jasmin D Busch; András Treszl; Silvia Münster; Janos Mester; Thorsten Derlin
Journal:  J Nucl Cardiol       Date:  2013-04-16       Impact factor: 5.952

6.  Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).

Authors:  Joachim H Ix; Ronit Katz; Ian H De Boer; Brian R Kestenbaum; Matthew A Allison; David S Siscovick; Anne B Newman; Mark J Sarnak; Michael G Shlipak; Michael H Criqui
Journal:  J Am Coll Cardiol       Date:  2009-09-22       Impact factor: 24.094

7.  Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats.

Authors:  Chengyun Liu; Jingjing Wan; Qunfang Yang; Benling Qi; Wen Peng; Xuelin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

8.  Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.

Authors:  Kelly E Beazley; Derek Banyard; Florence Lima; Stephanie C Deasey; Dmitry I Nurminsky; Mikhail Konoplyannikov; Maria V Nurminskaya
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-01       Impact factor: 8.311

9.  The vascular Ca2+-sensing receptor regulates blood vessel tone and blood pressure.

Authors:  M Schepelmann; P L Yarova; I Lopez-Fernandez; T S Davies; S C Brennan; P J Edwards; A Aggarwal; J Graça; K Rietdorf; V Matchkov; R A Fenton; W Chang; M Krssak; A Stewart; K J Broadley; D T Ward; S A Price; D H Edwards; P J Kemp; D Riccardi
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-04       Impact factor: 4.249

10.  Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries.

Authors:  Mei Y Speer; Hsueh-Ying Yang; Thea Brabb; Elizabeth Leaf; Amy Look; Wei-Ling Lin; Andrew Frutkin; David Dichek; Cecilia M Giachelli
Journal:  Circ Res       Date:  2009-02-05       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.